We’ve talked about clinical trial readiness repeatedly in this space. Probably we all, as an industry, have a good sense of what that means — or what it used to mean. The definition has acquired a whole new dimension in recent days. For example, this post was originally planned to be about a theoretical subset of sites
We are all finding ways personally and professionally to meet the challenge posed by COVID-19.
Earlier this month, as the threat of COVID-19 was becoming increasingly clear, we at ArcheMedX took decisive action to protect our employees, their families, and our business partners by freezing all travel, ensuring we could work
We recently spoke with Kevin M. Crawford, head of clinical operations at Tenax Therapeutics, a specialty pharmaceutical company based in Morrisville, North Carolina, that focuses on identifying, developing, and commercializing products to address cardiovascular and pulmonary diseases. We wanted to share these excerpts from the conversation:
You’ve talked about the importance of telling your story. Can you expound on that?
At Tenax therapeutics, we're
The threat of Coronavirus (COVID-19) is real and spreading. The most vulnerable among us (the elderly, immunocomprised individuals, and those with underlying health conditions) are at high risk of suffering from this virus. Public health experts and the CDC are urging more extreme social distancing, yet too many of us
As the coronavirus continues to spread and dominate the media, we are inundated with advice on what to do: How to boost our immunity, how to conduct business, how to wash our hands. If you are about to launch a clinical trial or initiate additional sites, consider this advice: press
Above image: countries with confirmed COVID-19 cases as of March 10th. Credit: CDC.gov
Below image: workers disinfecting streets in Xiaogon city, China. Credit: AFP via Getty Images.
It often takes adversity to spur creativity and innovation. Events that threaten our safety or shake our confidence alarm us, and often compel us to
We recently spoke with Joann Peters, Vice President Clinical Operations at Geneos Therapeutics, a biotech focused on developing personalized, tumor-targeted immunotherapies. The company is based in Plymouth Meeting, PA. We wanted to share these excerpts from the conversation:
What are the biggest and/or most common challenges you meet with during the
After record attendance and a high energy atmosphere at SCOPE 2020 in Orlando last week, the ArcheMedX team wanted to share our key takeaways:
With an entire track dedicated to Quality & Monitoring it is clear that whether you are focused on your broader risk-based quality management strategy or still zoomed
We recently talked with Mike Keens, Chief Operating Officer at Firma Clinical Research, a clinical research service provider specializing in patient-focused trial designs, often with at-home visit support. We wanted to share these excerpts from the conversation:
What do you see as the biggest or most common challenges to preparation for,